search
Back to results

Blink Restoration in Patients With Facial Nerve Palsy (NEURO-BLINK)

Primary Purpose

Facial Nerve Palsy

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
NEURO-BLINK Device
Sponsored by
Kantonsspital Aarau
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Facial Nerve Palsy focused on measuring neurostimulation, orbicularis oculi

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age over 18
  • Facial palsy
  • Lagophthalmus

Exclusion Criteria:

  • Minors
  • Pacemaker or defibrillator
  • Vulnerable population
  • Patients in emergency situations
  • Allergies on the sticky electrodes and MD metallic sensors

Sites / Locations

  • Ophthalmology Department Cantonal Hospital AarauRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients with facial nerve palsy and lagophthalmus

Arm Description

There is only one arm in this study. The investigators examine if the medical device can achieve a painless blinking in patients with facial nerve palsy and lagophthalmus.

Outcomes

Primary Outcome Measures

External electrical stimulation for a painless eye closure - Percentage of Eye closure (Parameter 1)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators aim to measure: Percentage of Eye closure during blink (between supported condition and pathological condition)
External electrical stimulation for a painless eye closure - Percentage of cornea coverage during blink (Parameter 2)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, we measure: Percentage of cornea coverage during blink (between supported condition and pathological condition) measured in mm
External electrical stimulation for a painless eye closure - Lagophthalmos reduction in mm (Parameter 3)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: Lagophthalmos reduction during closed eyes (between supported condition and pathological condition) measured in mm
External electrical stimulation for a painless eye closure - Visual acuity (Parameter 4)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: Visual acuity before and after the treatment through electronic Snellen charts
External electrical stimulation for a painless eye closure - influence upon corneal eye dryness (Parameter 5)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: eye dryness before and after the treatment through Oxford scale
External electrical stimulation for a painless eye closure - influence upon quality of life in reference to eye dryness (Parameter 6)
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: dry eye questionnaire through OSDI and McGill quality of life

Secondary Outcome Measures

Full Information

First Posted
October 30, 2021
Last Updated
September 7, 2022
Sponsor
Kantonsspital Aarau
Collaborators
ETH Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT05504473
Brief Title
Blink Restoration in Patients With Facial Nerve Palsy
Acronym
NEURO-BLINK
Official Title
Blink Restoration in Patients With Facial Nerve Palsy
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 1, 2022 (Actual)
Primary Completion Date
May 31, 2024 (Anticipated)
Study Completion Date
October 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kantonsspital Aarau
Collaborators
ETH Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is a non-blinded single armed pilot study aiming to apply a newly created medical device in patients with seventh nerve palsy suffering from lagophthalmus in order to determine the best way for neuromuscular stimulation of the orbicularis oculi muscle and facial nerve in order to enable eyelid closure (blink). Initially, a tailored external neurostimulation prototype will be created in collaboration with the ETH for patients with facial nerve palsy and lagophthalmos. Aim of this study is to create an efficient, safe and comfortable medical device that can achieve an effective blinking through external electrical neuromuscular stimulation of the orbicularis oculi in patients with facial palsy and lagophthalmos. Such a device can become an essential part of facial palsy treatment.
Detailed Description
Facial paralysis rates are reported to be 4/10,000 per annum leading to facial asymmetry and impairs essential facial functions, including blinking, protection of the cornea, lip competence, mastication, speaking, but also has psychosocial penalties. Facial animation is orchestrated by the facial muscles directed by the facial nucleus through a network of the facial nerve and its branches. The facial nerve (CNVII) plays a critical role in multiple complex functions of human life including mastication, speech, and successful social communication through expression of mood and emotion. The absence of facial nerve's function can be a result of a developmental anomaly, of a stroke leading to a damage to the central segment of this nerve (facial nucleus in the pons, motor cortex, or connections between the two), an iatrogenic or traumatic injury, a neoplastic infiltration or an infectious (e.g., borreliosis and herpes zoster), or idiopathic inflammation of the extratemporal segments of the facial nerve. The peripheral facial paralysis (PFP), resulting from affection of the seventh nerve is the most common pathology of the cranial pairs. The facial nerve normally emits electrical impulses to give muscles their tone and shape. Therefore, when it is damaged, the muscles become weak and floppy. External electrical stimulation can mimic the electrical nerve impulses and help restore muscle tone in patients with facial palsy. Applications involving nerve stimulation can be divided into three separate categories: therapeutic electrical stimulation (TES), neuromodulatory stimulation (NMS), and functional electrical stimulation (FES). By FES standards, neural prosthetic reanimation of the eyelids for blink restoration is a relatively simple and low-risk application. Restoration of blinking involves a single muscle, the orbicularis oculi. The presence of the nerve is not required for external electrical stimulation to be used. External electrical neuromuscular stimulation can try to mimic the electrical nerve impulses in patients with facial palsy. However, no device has yet been proven appropriate for daily use. The research question the investigators aim to answer is whether an efficient, safe and comfortable medical device that can achieve an effective blinking through external electrical neuromuscular stimulation of the orbicularis oculi in patients with facial palsy and lagophthalmos can be created. The stimulation will be provided in the form of charge balanced biphasic square pulses as shown in the image below at a frequency of 100Hz. The investigators mainly want to determine the functionality of a constant external electrostimulation for the patients. Blinking sufficiency will be evaluated qualitatively and quantitatively through surveys and observations. The investigators aim to recruit initially 10 patients suffering from lagophthalmos due to facial nerve palsy, who will be invited to wear the device. The exact parameters needed for the neurostimulation and symptoms of patients or any adverse events will be documented on the case report form (CRF).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Facial Nerve Palsy
Keywords
neurostimulation, orbicularis oculi

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients with facial nerve palsy and lagophthalmus
Arm Type
Experimental
Arm Description
There is only one arm in this study. The investigators examine if the medical device can achieve a painless blinking in patients with facial nerve palsy and lagophthalmus.
Intervention Type
Device
Intervention Name(s)
NEURO-BLINK Device
Intervention Description
The NEURO-BLINK is a class IIa medical device that intends to restore the blink function in patients with facial palsy through the application of transcutaneous electrical stimulation.
Primary Outcome Measure Information:
Title
External electrical stimulation for a painless eye closure - Percentage of Eye closure (Parameter 1)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators aim to measure: Percentage of Eye closure during blink (between supported condition and pathological condition)
Time Frame
2 year
Title
External electrical stimulation for a painless eye closure - Percentage of cornea coverage during blink (Parameter 2)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, we measure: Percentage of cornea coverage during blink (between supported condition and pathological condition) measured in mm
Time Frame
2 year
Title
External electrical stimulation for a painless eye closure - Lagophthalmos reduction in mm (Parameter 3)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: Lagophthalmos reduction during closed eyes (between supported condition and pathological condition) measured in mm
Time Frame
2 year
Title
External electrical stimulation for a painless eye closure - Visual acuity (Parameter 4)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: Visual acuity before and after the treatment through electronic Snellen charts
Time Frame
2 year
Title
External electrical stimulation for a painless eye closure - influence upon corneal eye dryness (Parameter 5)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: eye dryness before and after the treatment through Oxford scale
Time Frame
2 year
Title
External electrical stimulation for a painless eye closure - influence upon quality of life in reference to eye dryness (Parameter 6)
Description
The investigators aim to use external electrical neuromuscular stimulation in order to achieve eye blinking/closure in 10 patients with lagophthalmos due to facial nerve palsy. In particular, the inverstigators measure: dry eye questionnaire through OSDI and McGill quality of life
Time Frame
2 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age over 18 Facial palsy Lagophthalmus Exclusion Criteria: Minors Pacemaker or defibrillator Vulnerable population Patients in emergency situations Allergies on the sticky electrodes and MD metallic sensors
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anthia Papazoglou
Phone
+41 62 838 50 05
Email
anthiap@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Markus Tschopp
Phone
+41 62 838 50 05
Email
markus.tschopp@ksa.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marcel Menke
Organizational Affiliation
Cantonal Hospital Aarau Ophthalmology Department
Official's Role
Study Chair
Facility Information:
Facility Name
Ophthalmology Department Cantonal Hospital Aarau
City
Aarau
State/Province
Aargau
ZIP/Postal Code
5001
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anthia Papazoglou
Email
anthiap@gmail.com
First Name & Middle Initial & Last Name & Degree
Markus Tschopp
Email
markus.tschopp@ksa.ch

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Blink Restoration in Patients With Facial Nerve Palsy

We'll reach out to this number within 24 hrs